ClinicalTrials.govpublic full text
Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).
sickle cell disease, deferasirox, icl670a, iron chelators, transfusional hemosiderosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892978
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.